Diagnosis and therapy of rheumatoid arthritis in the future

Modern Rheumatology

Volumn 11, Issue 4, 2001, Pages 286-291

  Matsui, Nobuo ^a   Waguri Nagaya, Yuko ^a   Taneda, Yoichi ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Agalactosyl IgG; Cyclooxygenase (COX) 2 selective inhibitor; Gliostatin; Magnetic resonance imaging (mri); Rheumatoid arthritis

Indexed keywords

EID: 75149140437     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-001-8057-z     Document Type: Review

References (16)

1. Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
2. Taneda Y, Matsui N, Yoshida Y, Nagaya Y, Mukofujiwara Y. MRI diagnosis of early rheumatoid arthritis (in Japanese). Riumachi-ka 1999;21:122-9.
3. Asai K, Hirano T, Kaneko S, Moriyama A, Nakanishi K, Isobe I, et al. A novel glial growth inhibitory factor, gliostatin, derived from neurofibroma. J Neurochem 1992;59:307-17.
4. Asai K, Nakanishi K, Isobe I, Eksioglu YZ, Hirano A, Hama K, et al. Neurotrophic action of gliostatin on cortical neurons: identity of gliostatin and platelet-derived endothelial cell growth factor. J Biol Chem 1992;267:20311-6.
5. Ishikawa F, Miyazono K, Hellman U, Drexler D, Wernstedt C, Hagiwara K, et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989;338:557-61.
6. Takeuchi M, Otsuka T, Matsui N, Asai K, Kato T, Tada T, et al. Aberrant production of gliostatin/platelet-derived endothelial cell growth factor in rheumatoid arthritis. Arthritis Rheum 1994;37:662-72.
7. Waguri Y, Otsuka T, Sugimura I, Matsui N, Asai K, Moriyama A, et al. Gliostatin/platelet-derived endothelial cell growth factor as a clinical marker of rheumatoid arthritis and its regulation in fibroblast-like synoviocytes. Br J Rheumatol 1997;36:315-21.
8. Waguri-Nagaya Y, Otsuka T, Sugimura I, Matsui N, Asai K, Nakajima K, et al. Synovial inflammation and hyperplasia induced by gliostatin/platelet-derived endothelial cell growth factor in rabbit knees. Rheumatol Int 2000;20:13-9.
9. Muro H, Waguri-Nagaya Y, Mukofujiwara Y, Iwahashi T, Otsuka T, Matsui N, et al. Autocrine induction of gliostatin/platelet derived endothelial cell growth factor (GLS/PD-ECGF) and GLS-induced expression of matrix metalloproteinases in rheumatoid arthritis synoviocytes. Rheumatology 1999;38:1195-202.
10. Feldmann M, Maini RN. The role of cytokines in the pathogenesis of rheumatoid arthritis. Rheumatology 1999;38 Suppl 2:3-7.
11. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985;310:452-7.
12. Takahashi N, Ishi I, Ishihara H, Mori M, Tejima S, Jefferis R, et al. Comparative structural study of N-linked oligosaccharides of human normal and pathological immunoglobulin G. Biochemistry 1987;26:1137-44.
13. Mukofujiwara Y, Otsuka T, Waguri Y, Matsui N, Asai K, Kato T, et al. Abnormal glycosylation of IgG as a clinical parameter in patients with rheumatoid arthritis: its constitutional analysis by HPLC. J Clin Biochem Nutr 1998;25:131-42.
14. Takubo N, Yamamoto T, Nakata S, Yamada Y. The clinical usefulness of measurement of the serum anti-agalactosyl IgG antibody values in the early onset RA (in Japanese). Riumachi-ka 1997;17:228-34.
15. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nature 1971;231:232-5.
16. Vane JR, Botting RM. Mechanism of action of antiinflammatory drugs. Scand J Rheumatol 1996;25 Suppl 102:9-12.